Back to Search Start Over

The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases.

Authors :
Zinatizadeh MR
Schock B
Chalbatani GM
Zarandi PK
Jalali SA
Miri SR
Source :
Genes & diseases [Genes Dis] 2020 Jul 18; Vol. 8 (3), pp. 287-297. Date of Electronic Publication: 2020 Jul 18 (Print Publication: 2021).
Publication Year :
2020

Abstract

The nuclear factor kappa B (NF-kB) family of transcription factors plays an essential role as stressors in the cellular environment, and controls the expression of important regulatory genes such as immunity, inflammation, death, and cell proliferation. NF-kB protein is located in the cytoplasm, and can be activated by various cellular stimuli. There are two pathways for NF-kB activation, as the canonical and non-canonical pathways, which require complex molecular interactions with adapter proteins and phosphorylation and ubiquitinase enzymes. Accordingly, this increases NF-kB translocation in the nucleus and regulates gene expression. In this study, the concepts that emerge in different cellular systems allow the design of NF-kB function in humans. This would not only allow the development for rare diseases associated with NF-kB, but would also be used as a source of useful information to eliminate widespread consequences such as cancer or inflammatory/immune diseases.<br />Competing Interests: The authors declared no conflict of interests.<br /> (© 2020 Chongqing Medical University. Production and hosting by Elsevier B.V.)

Details

Language :
English
ISSN :
2352-3042
Volume :
8
Issue :
3
Database :
MEDLINE
Journal :
Genes & diseases
Publication Type :
Academic Journal
Accession number :
33997176
Full Text :
https://doi.org/10.1016/j.gendis.2020.06.005